## **Core Concept**
The carry-over effect, also known as the residual effect or cross-over effect, refers to a phenomenon observed in clinical trials or pharmacological studies where the effect of a treatment or intervention persists or influences the outcome of a subsequent treatment or period. This concept is particularly relevant in the context of crossover trials, a type of clinical trial where participants receive a sequence of different treatments.

## **Why the Correct Answer is Right**
In the context of pharmacology and clinical trials, the carry-over effect is most commonly associated with **crossover trials (C)**. These are studies where each participant receives a sequence of different treatments (e.g., treatment A followed by treatment B, or vice versa). The carry-over effect occurs when the effect of the first treatment influences the outcome of the second treatment, potentially leading to biased results if not properly accounted for in the study design.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Without specific details on what Option A refers to, it's not possible to directly address its incorrectness. However, based on the context, it's clear that A is not related to crossover trials.
- **Option B:** Similarly, without specifics, we can't directly refute B, but given that C is the correct answer related to crossover trials, B likely doesn't pertain to this concept.
- **Option D:** This option is also unspecified but is incorrect because C is identified as the correct context in which the carry-over effect is seen.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl to remember is that crossover trials are particularly susceptible to carry-over effects, which can complicate the interpretation of results. To mitigate this, washout periods are often included between treatments to allow the effects of the first treatment to dissipate before administering the second treatment.

## **Correct Answer:** C. Crossover trials.